Dow Jones

39 118,86

-0,12%

DAX

Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
USOTC
Acura Pharmaceuticals Inc (CE) (ACUR)
Acura Pharmaceuticals Inc (CE) (ACUR) Actualités

ACUR

Acura Pharmaceuticals (CE) (ACUR)

Acura Pharmaceuticals Inc (CE)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:USOTC:ACUR

1 2 3 4 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
04/06/2024	17h00	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
15/05/2024	14h00	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
02/01/2024	21h23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
30/06/2023	19h00	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
28/06/2023	14h01	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
15/05/2023	19h02	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
05/01/2023	22h10	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
31/03/2022	22h13	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
14/02/2022	18h55	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
15/11/2021	22h53	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
01/06/2021	22h11	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
12/04/2021	16h01	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
31/03/2021	22h17	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
07/08/2019	20h51	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
12/07/2019	16h02	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
31/07/2018	22h09	Edgar (US Regulatory)	Withdrawal of Registration Statement (rw)	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
10/04/2018	15h42	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
14/02/2018	14h56	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
22/01/2018	13h01	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
27/09/2017	23h23	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
03/08/2017	17h48	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
28/07/2017	15h38	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
14/03/2017	15h15	Edgar (US Regulatory)	(25-NSE)	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
15/02/2017	22h15	GlobeNewswire Inc.	Acura Pharmaceuticals Common Stock To Trade On The OTCQB Market	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
03/02/2017	23h17	Edgar (US Regulatory)	Securities Registration Statement (s-1)	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
03/01/2017	22h15	GlobeNewswire Inc.	Acura Pharmaceuticals Exploring Strategic Alternatives	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
18/10/2016	12h30	GlobeNewswire Inc.	KemPharm Announces Licensing Agreement with Acura Pharmaceuticals for Aversion® Abuse-Deterrent Technology	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
31/03/2016	12h01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
23/03/2016	22h12	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3/a)	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
09/03/2016	22h11	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)